6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Bunaciu, Rodica P ^a   Yen, Andrew ^a  

^a Cornell University ^*  (United States)

Author keywords

6 Formylindolo(3,2 b)carbazole (FICZ); Differentiation; HL 60; Neutrophil; Retinoic acid (RA)

Indexed keywords

6 FORMYLINDOLO (3,2 B)CARBAZOLE; AROMATIC HYDROCARBON RECEPTOR; CARBAZOLE DERIVATIVE; CD11B ANTIGEN; CD38 ANTIGEN; CYTOCHROME P450 1A2; MITOGEN ACTIVATED PROTEIN KINASE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P47; PROTEIN TYROSINE KINASE; RAF PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRF1; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MYELOID LEUKEMIA; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARBAZOLES; CELL CYCLE; CELL DIFFERENTIATION; DRUG SYNERGISM; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 84877142085     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-39     Document Type: Article

References (52)

1. Bunaciu RP, Yen A. Activation of the aryl hydrocarbon receptor AhR promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4. Cancer Res 2011, 71:2371-2380. 10.1158/0008-5472.CAN-10-2299, 3391168, 21262915.
2. Harper PA, Giannone JV, Okey AB, Denison MS. In vitro transformation of the human Ah receptor and its binding to a dioxin response element. Mol Pharmacol 1992, 42:603-612.
3. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, Takahashi S, Kouzmenko A, Nohara K, Chiba T, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007, 446:562-566. 10.1038/nature05683, 17392787.
4. Ma Q. Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab 2001, 2:149-164. 10.2174/1389200013338603, 11469723.
5. Soprano DR, Soprano KJ. Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J Nutr 2003, 133:277S-281S.
6. Shenefelt RE. Gross congenital malformations. Animal model: treatment of various species with a large dose of vitamin a at known stages in pregnancy. Am J Pathol 1972, 66:589-592. 2032719, 4551297.
7. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, Fujii-Kuriyama Y. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 1997, 2:645-654.
8. Hayashida Y, Kawamura T, Hori-e R, Yamashita I. Retionic acid and its receptors are required for expression of aryl hydrocarbon receptor mRNA and embryonic development of blood vessel and bone in the medaka fish, Oryzias latipes. Zoolog Sci 2004, 21:541-551. 10.2108/zsj.21.541, 15170058.
9. Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol 2010, 24:359-369. 10.1210/me.2009-0346, 2817602, 20032195.
10. Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res 2010, 70:212-220. 10.1158/0008-5472.CAN-09-3090, 2939500, 19996281.
11. Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, Pettersson S, Poellinger L, Fujii-Kuriyama Y, Taniguchi S, Kawajiri K. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice. Carcinogenesis 2013,
12. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348. 10.1126/science.1191536, 3033342, 20688981.
13. Bock KW. The human Ah receptor: hints from dioxin toxicities to deregulated target genes and physiologic functions. Biol Chem 2013, 394:729-739.
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
15. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391. 10.1016/S0092-8674(00)81769-9, 9814708.
16. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526, 18029452.
17. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 1998, 58:3163-3172.
18. Congleton J, MacDonald R, Yen A. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells. Leukemia 2012, 26:1180-1188. 10.1038/leu.2011.390, 3310950, 22182854.
19. Shen M, Yen A. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells. Cancer Res 2008, 68:8761-8769. 10.1158/0008-5472.CAN-08-1058, 18974118.
20. Yen A, Varvayanis S, Smith JL, Lamkin TJ. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells. Eur J Cell Biol 2006, 85:117-132. 10.1016/j.ejcb.2005.09.020, 16439309.
21. Shen M, Bunaciu RP, Congleton J, Jensen HA, Sayam LG, Varner JD, Yen A. Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells. Leuk Lymphoma 2011, 52:2372-2379. 10.3109/10428194.2011.603449, 21740303.
22. Marchisio M, Bertagnolo V, Colamussi ML, Capitani S, Neri LM. Phosphatidylinositol 3-kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocytic differentiation. Biochem Biophys Res Commun 1998, 253:346-351. 10.1006/bbrc.1998.9787, 9878540.
23. Bertagnolo V, Grassilli S, Bavelloni A, Brugnoli F, Piazzi M, Candiano G, Petretto A, Benedusi M, Capitani S. Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. J Proteome Res 2008, 7:3729-3736. 10.1021/pr7008719, 18642942.
24. Pinel-Marie ML, Sparfel L, Desmots S, Fardel O. Aryl hydrocarbon receptor-dependent induction of the NADPH oxidase subunit NCF1/p47 phox expression leading to priming of human macrophage oxidative burst. Free Radic Biol Med 2009, 47:825-834. 10.1016/j.freeradbiomed.2009.06.025, 19559082.
25. Korn T. How T cells take developmental decisions by using the aryl hydrocarbon receptor to sense the environment. Proc Natl Acad Sci USA 2010, 107:20597-20598. 10.1073/pnas.1015420107, 2996416, 21084638.
26. Yen A, Roberson MS, Varvayanis S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev Biol Anim 1999, 35:527-532. 10.1007/s11626-999-0063-z, 10548434.
27. Wang J, Yen A. A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest. J Biol Chem 2008, 283:4375-4386.
28. Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK. Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 2005, 17:215-224. 10.1016/j.molcel.2004.11.055, 15664191.
29. Hekman M, Fischer A, Wennogle LP, Wang YK, Campbell SL, Rapp UR. Novel C-Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation. FEBS Lett 2005, 579:464-468. 10.1016/j.febslet.2004.11.105, 15642359.
30. Ingley E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal 2012, 10:21. 10.1186/1478-811X-10-21, 3464935, 22805580.
31. Reiterer G, Bunaciu RP, Smith JL, Yen A. Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells. FEBS Lett 2008, 582:2508-2514. 10.1016/j.febslet.2008.06.016, 2585509, 18571505.
32. Shen M, Yen A. c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest. J Biol Chem 2009, 284:25664-25677. 10.1074/jbc.M109.014241, 2757968, 19635790.
33. Katagiri K, Yokoyama KK, Yamamoto T, Omura S, Irie S, Katagiri T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem 1996, 271:11557-11562. 10.1074/jbc.271.19.11557, 8626717.
34. Donella-Deana A, Cesaro L, Ruzzene M, Brunati AM, Marin O, Pinna LA. Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity. Biochemistry 1998, 37:1438-1446. 10.1021/bi971332s, 9477973.
35. Reiterer G, Yen A. Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res 2007, 67:7765-7772. 10.1158/0008-5472.CAN-07-0014, 17699781.
36. Rinsky RA, Hornung RW, Silver SR, Tseng CY. Benzene exposure and hematopoietic mortality: A long-term epidemiologic risk assessment. Am J Ind Med 2002, 42:474-480. 10.1002/ajim.10138, 12439870.
37. Widerak M, Ghoneim C, Dumontier MF, Quesne M, Corvol MT, Savouret JF. The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism. Biochimie 2006, 88:387-397. 10.1016/j.biochi.2005.11.007, 16480812.
38. Kumar MB, Perdew GH. Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. Gene Expr 1999, 8:273-286.
39. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-414. 10.1016/S0092-8674(00)81118-6, 8616895.
40. Yang-Yen HF, Zhang XK, Graupner G, Tzukerman M, Sakamoto B, Karin M, Pfahl M. Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation. New Biol 1991, 3:1206-1219.
41. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol 2002, 181:116-123. 10.1006/taap.2002.9403, 12051995.
42. Klinge CM, Kaur K, Swanson HI. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1. Arch Biochem Biophys 2000, 373:163-174. 10.1006/abbi.1999.1552, 10620335.
43. Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM, Pfahl M. COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol 1992, 12:4666-4676. 360393, 1328857.
44. Sassano A, Altman JK, Gordon LI, Platanias LC. Statin-dependent activation of protein kinase Cdelta in acute promyelocytic leukemia cells and induction of leukemic cell differentiation. Leuk Lymphoma 2012, 53:1779-1784. 10.3109/10428194.2012.668287, 22356114.
45. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, et al. Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem 2003, 278:32544-32551. 10.1074/jbc.M301523200, 12805378.
46. Yen A, Varvayanis S. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is. In Vitro Cell Dev Biol Anim 2000, 36:249-255. 10.1290/1071-2690(2000)036<0249:RAIAOP>2.0.CO;2, 10852350.
47. Hoyos B, Jiang S, Hammerling U. Location and functional significance of retinol-binding sites on the serine/threonine kinase, c-Raf. J Biol Chem 2005, 280:6872-6878. 10.1074/jbc.M412695200, 15591313.
48. Hoyos B, Imam A, Korichneva I, Levi E, Chua R, Hammerling U. Activation of c-Raf kinase by ultraviolet light. Regulation by retinoids. J Biol Chem 2002, 277:23949-23957. 10.1074/jbc.M110750200, 11971897.
49. Mukai R, Shirai Y, Saito N, Fukuda I, Nishiumi S, Yoshida K, Ashida H. Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction. Arch Biochem Biophys 2010, 501:134-141. 10.1016/j.abb.2010.05.002, 20450880.
50. Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 1996, 52:1599-1612. 10.1016/S0006-2952(96)00566-7, 8937476.
51. Kauss MA, Reiterer G, Bunaciu RP, Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Exp Cell Res 2008, 314:2999-3006. 10.1016/j.yexcr.2008.07.015, 2580735, 18692045.
52. Brooks SC, Kazmer S, Levin AA, Yen A. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood 1996, 87:227-237.